GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ARYX THERAPEUTICS I (ARYX) [hlAlert]

ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology
to design structurally unique molecules that retain the efficacy of these original drugs but are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these compounds. ARYx currently has three products in Phase 2 clinical trials: ATI-7505 for the treatment of various gastrointestinal disorders, ATI-5923 for the treatment of patients at risk for the formation of dangerous blood clots, and ATI-2042 for the treatment of atrial fibrillation.
( Total: 5 Current Stock Recommendations )
ARYX THERAPEUTICS I   (5)
Buy 100%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
None
3 Months Gains
down 19.47 %
ARYX THERAPEUTICS I (ARYX) rated Perform by Oppenheimer
Monday,  Feb 22, 2010  8:25 AM ET

Rating:
Buy ARYX
down 99.90 %

Rating:
Buy ARYX
down 99.90 %

Rating:
Buy ARYX
down 99.92 %

Rating:
Buy ARYX
down 99.90 %

Rating:
Buy ARYX
down 19.47 %

Rating:
Buy ARYX
down 99.96 %

Rating:
Buy ARYX
down 99.96 %

Rating:
Buy ARYX
down 99.96 %

Rating:
Buy ARYX
down 99.96 %
ARYX THERAPEUTICS I (ARYX) rated Buy
Tuesday,  Dec 18, 2007  9:25 AM ET

Your Recent Stocks
SymbolLastChange
ARYX 0.00   0.00 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy